The BEAR Program for Women With Trauma Who Have Suicidal Thoughts

Study acronym: BEAR-SI
StatusCompleted
PhaseNot applicable
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial completed Show 5 more changesShow less
    • Final enrollment: 5 participants (planned 30)
    • Primary completion date changed from estimate of Aug 2027 to Sep 1, 2026
    • Eligibility criteria expanded, about 10 words
    • Site details revised
    • Publications: details revised at 4 of 5 entries
  2. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jan 2026 to Feb 17, 2026
    • Site details revised
    v2
  3. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Stanford University
635 trials monitored
See 45 trials at risk
Anxiety
3,284 trials monitored
See 154 trials at risk
Depression
3,069 trials monitored
See 170 trials at risk
PTSD
891 trials monitored
See 54 trials at risk
The current study aims to test the feasibility of a new form of group therapy for women who have a history of interpersonal trauma and current suicidal ideation. The Building Empowerment and Resilience (BEAR) Therapeutic group has been adapted for women who have experienced trauma and have current suicidal ideation. It incorporates psychological skills, psychoeducation about trauma and gender-based violence, and physical self-defense training, all within a therapeutic process. It will be implemented with women who have experienced interpersonal trauma (physical, sexual, or emotional abuse/neglect) and experience various mental health difficulties, including suicidal ideation. We aim to assess the feasibility to recruit and implement the BEAR group. Our ultimate aim is to assess whether the program can effect self-efficacy and suicidal ideation.
Trial Details
NCT Number NCT07346638
Lead Sponsor Stanford University
Conditions
(from sponsor)		 Interpersonal Trauma, Depression, PTSD, Anxiety, Suicidal Ideations, Sexual Assault
Related terms Anxiety Disorders, Depression, Stress Disorders, Post-Traumatic, Suicidal Ideation
Enrollment 5 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov